Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Cytokeratin, HMW Antibody (KRTH/1076) - Azide and BSA Free, Novus Biologicals™

Mouse Monoclonal Antibody
Supplier: Novus Biologicals NBP2476900.2MG
Description
Cytokeratin, HMW Monoclonal antibody specifically detects Antigen in Human, Rat samples. It is validated for Enzyme Linked Immunosorbent Assay, Flow Cytometry, Immunofluorescence, Immunohistochemistry (Paraffin), Western Blotting.Specifications
Cytokeratin, HMW | |
Monoclonal | |
1.0 mg/mL | |
Western Blot : 0.5 - 1.0 ug/ml, Flow Cytometry : 0.5 - 1 ug/million cells in 0.1 ml, ELISA, Immunohistochemistry-Paraffin : 0.25 - 0.5 ug/ml, Immunofluorescence : 1 - 2 ug/ml, CyTOF-ready | |
CK-2P, cytokeratin 2, Cytokeratin-2P, HUMCYT2A, K2P, K76, keratin 76, keratin, type II cytoskeletal 2 oral, Keratin-76, KRT2Bcytokeratin-2P, KRT2Pkeratin 2p, KRT76, Type-II keratin Kb9 | |
Mouse | |
Protein A or G purified | |
RUO | |
51350 | |
Human, Rat | |
Purified |
Western Blot, Flow Cytometry, ELISA, Immunohistochemistry (Paraffin), Immunofluorescence, CyTOF | |
KRTH/1076 | |
Unconjugated | |
PBS with No Preservative | |
KRT76 | |
Recombinant human KRT76 protein | |
0.2 mg | |
Primary | |
This MAb recognizes basic (Type II or HMW) cytokeratins, which include 67kDa (CK1); 64kDa (CK3); 59kDa (CK4); 58kDa (CK5); 56kDa (CK6); 52kDa (CK8). Twenty human keratins are resolved with two-dimensional gel electrophoresis into acidic (pI 6.0) subfamilies. The acidic keratins have molecular weights (MW) of 56.5, 55, 51, 50, 50, 48, 46, 45, and 40kDa. Many studies have shown the usefulness of keratins as markers in cancer research and tumor diagnosis. | |
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles. | |
IgG1 κ |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction